ADHD medication shortage 2026: what's short right now

As of August 2026 the shortage that started in October 2022 is not over, but it has narrowed to a specific place: generic immediate-release mixed amphetamine salts. The DEA raised the 2026 amphetamine quota roughly 14% above what it first proposed, to 24,234,443 grams of d,l-amphetamine, and generic Adderall is still the hardest thing on this list to fill. Quota stopped being the bottleneck a while ago.

This is a status page, not medical advice. Nothing here tells you what to take or at what dose; that stays between you and your prescriber. It's sourced from the DEA's own quota order and shortage databases, and we re-check it monthly because a stale shortage page is worse than none. Last checked August 2, 2026.

Status by drug

Drug	Status, August 2026	The specific problem
Generic amphetamine salts, IR (generic Adderall)	Still short	The hardest fill in the category. Availability varies by pharmacy and by strength.
Brand Adderall / Adderall XR	Generally available	Costs what brand costs.
Generic lisdexamfetamine (generic Vyvanse)	Spotty	Manufacturers cite active-ingredient supply; specific strengths go missing while others ship.
Brand Vyvanse	Generally available	Still $200+ cash three years after generics launched.
Methylphenidate (Ritalin, Concerta and generics)	Generally available	2026 quota held flat at 2025 levels despite manufacturer requests to raise it.

Two caveats that matter more than the table. Shortage databases describe manufacturer-level supply, not what's on the shelf at your pharmacy, and those can disagree completely in either direction. And "generally available" at national scale is no comfort when four pharmacies in your town are out.

The quota is not the bottleneck anymore

For three years the standard explanation was that the DEA capped production too tightly. That story has expired.

The 2026 quota order, published January 5, 2026 after 5,044 public comments, set these ceilings:

Substance	2026 quota (grams)
Methylphenidate (for sale)	58,283,000
Lisdexamfetamine	51,290,743
d-Amphetamine (for sale)	26,450,000
d,l-Amphetamine	24,234,443

Lisdexamfetamine's ceiling is over 51 million grams. Generic lisdexamfetamine is still spotty. Those two facts sitting next to each other are the whole argument: a ceiling nobody is hitting doesn't explain an empty shelf.

The isomer answer, which nobody covers

The most interesting thing in the 2026 order went almost entirely unreported.

Manufacturers argued they can't obtain the right ratio of d-amphetamine to l-amphetamine to make mixed amphetamine salts. Adderall isn't one molecule; it's four salts in a fixed 3:1 d-to-l ratio, and if you can't get l-amphetamine you can't make it no matter how much d-amphetamine you hold.

The DEA's response was to reject the framing:

"DEA does not allocate d-amphetamine and l-amphetamine quotas in a fixed one-to-one ratio because the manufacturers do not request d-amphetamine and l-amphetamine quotas in a 1:1 ratio."

The agency's position is that manufacturers ask for quota as d,l-amphetamine, a 50:50 racemic mixture, rather than requesting the isomers separately, and that current allocations are sufficient to make approved products under normal manufacturing standards. In other words, DEA is calling this a quota-request methodology problem rather than a supply constraint.

Somebody is wrong here, and the answer determines whether generic Adderall gets easier this year. My read: when the regulator and the manufacturers are arguing about paperwork rather than grams, the patient waiting at a counter is not close to the front of anyone's mind.

What to do this month

Practical, not medical. Your prescriber decides everything clinical.

Call before you drive. Ring pharmacies and ask whether they have your specific drug, strength, and quantity in stock right now. Strength is the part people leave out, and it's frequently the thing that's missing.

Ask your prescriber about the switch question before you're out, not on the day you run dry. Methylphenidate-based options are the most available category on this list right now, and whether that's appropriate for you is a clinical call nobody on the internet can make. We wrote plain-English explainers of Adderall vs Vyvanse and Concerta vs Ritalin so that conversation starts from something.

Don't let the prescription expire while you hunt. Controlled-substance rules make a lapsed prescription a much bigger problem than a delayed fill.

Check the cash price even with insurance. For lisdexamfetamine the coupon price is routinely a fraction of the sticker, and we documented the gap in our Vyvanse pricing piece.

What would actually change this

Watch two things. First, whether manufacturers begin requesting d- and l-amphetamine quota separately, which would test the DEA's claim directly within one quota cycle. Second, whether active-ingredient supply for lisdexamfetamine steadies, since that quota ceiling is generous enough that persistent gaps point at the supply chain rather than the regulator.

Neither of those resolves before the next quota cycle. Plan on this being the shape of things through 2026.

We re-check this page monthly and change the date at the top when we do. If the date above is more than five weeks old, treat every row as suspect and call your pharmacy.

Sources

• Established Aggregate Production Quotas for 2026, DEA, Federal Register, January 5, 2026
• Adjustment to the 2025 APQ for d-Amphetamine and Methylphenidate, DEA
• Adjustment to the APQ for lisdexamfetamine and d-amphetamine, DEA, September 2025
• ASHP current drug shortages: lisdexamfetamine capsules
• FDA drug shortages database
• Our breakdown of generic Vyvanse pricing

Status verified August 2, 2026 against the DEA's 2026 quota order and published shortage databases. Availability at any individual pharmacy varies daily and no database tracks that. This is informational reporting, not medical advice.